Key result
Surgeon-performed percutaneous LAAO achieves ~97% procedural success with low adverse event rates.
Why the study?
Percutaneous left atrial appendage occlusion is dominated by cardiologists, prompting an evaluation of results when performed solely by cardiac surgeons.
Is percutaneous left atrial appendage occlusion performed solely by cardiac surgeons safe and effective in patients with nonvalvular atrial fibrillation?
Cohort (n=223)
Yes
Is percutaneous left atrial appendage occlusion performed solely by cardiac surgeons safe and effective in patients with nonvalvular atrial fibrillation?
Percutaneous LAAO can be safely and effectively performed by cardiac surgeons with high procedural success and low complication rates.
Answers are grounded in this paper and cite their sources.
May support cardiac surgeon–performed LAAO in nonvalvular AF; leaves open need for randomized confirmation before practice change.
OBJECTIVES: Percutaneous left atrial appendage (LAA) occlusion (LAAO) is a procedure dominated by cardiologists. The aim of our study was to present the results of percutaneous LAAO performed solely by cardiac surgeons. METHODS: Two hundred twenty-three consecutive patients with nonvalvular atrial fibrillation underwent percutaneous LAAO in two cardiac surgery sites. In the first center, all 84 LAAO procedures were performed with the endocardial LAA occluders: 60 cases with the Amulet and 24 cases with the LAmbre. In the second center, all 139 LAAO procedures were performed with the LARIAT epicardial device. The procedure was successful in 97.3% of cases. Procedural or device-related adverse events were noted in 4.4% (n = 10) of cases: one periprocedural cardiac arrest, one aortic injury, one gastrointestinal bleeding, three cases of vascular access complications, and four cardiac tamponades. After a follow-up of 40.3 ± 17.3 months, 78.4% of patients were alive, with the annual mortality rate of 5.3%. Compared to the predicted risk, the observed incidence of thromboembolism was lower by 71%, and the bleeding incidence was lower by 69%. CONCLUSIONS: Percutaneous LAAO procedures can be safely performed by cardiac surgeons, with no cardiological assistance. LAAO done by surgeons is safe and effective, and periprocedural and long-term outcomes are excellent. Cardiac surgeons should be trained in both types of LAAO: endocardial and epicardial.
No takes yet. Share an insight, caveat, or question.
Litwinowicz et al. (2020) conducted a cohort in Nonvalvular atrial fibrillation (n=223). Percutaneous left atrial appendage occlusion (LAAO) performed by cardiac surgeons vs. Predicted risk (for long-term outcomes) was evaluated on Procedural success. Percutaneous left atrial appendage occlusion performed solely by cardiac surgeons achieved a 97.3% procedural success rate with a 4.4% rate of procedural or device-related adverse events.
Synapse has enriched 10 related papers. Consider them for comparative context: